This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Survey: Cell & Gene Therapy COVID-19 Response

Share this article

After the sweep of COVID-19 across the world, the cell and gene therapy sector found itself in a convenient position to produce vaccines and treatments in the fight against the virus, with growing attention from governments and investors alike.

Cell & Gene Therapy Manufacturing & Commercialization is conducting a global survey to find out what innovation has been developing across the industry in response to COVID-19. The final report will reveal the different strategies and scale in which companies in the space have taken up new products and partnerships as a result of the pandemic.

Completing the survey will take just a few minutes and will give you exclusive early access to the final report. All answers will remain anonymous and everyone who completes the survey by Sunday 28 March 2021 will be entered into a prize draw for a free conference pass to their choice of Cell & Gene Therapy conferences

Click here to take part in the survey.

We’re excited to see the results of this study and we hope you are too.

Share this article

Upcoming event

Cell & Gene Therapy Manufacturing & Commercialization Asia

11 - 14 Apr 2022, Presented in Japan Standard Time (JST)
The ONLY Cell and Gene Therapy event in Asia to help you fast track manufacturing & commercialization across borders
Go to site